Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was ...